Q.2 Ames test is used to determine

• (A) The mutagenicity of a chemical
• (B) Carcinogenicity of a chemical
• (C) Both mutagenicity and carcinogenicity of a chemical
• (D) Toxicity of a chemical

  The Ames test is a cornerstone bacterial assay in toxicology and genetics for screening potential mutagens. Developed by Bruce Ames, it identifies chemicals causing DNA mutations using histidine-requiring Salmonella strains. This SEO-optimized article solves the MCQ with the correct answer—(A) The mutagenicity of a chemical—and explains all options for exam prep in biotechnology or microbiology.

  What is the Ames Test?

  The Ames test detects mutagenic potential by observing reverse mutations in auxotrophic bacteria. Special Salmonella typhimurium strains (e.g., TA98, TA100) can’t synthesize histidine due to specific mutations. Exposure to a test chemical, often with rat liver extract (S9) for metabolic activation, allows revertant colonies to grow on histidine-free media—indicating mutagenesis.

  Correct Answer: (A) The mutagenicity of a chemical
  This assay specifically measures a chemical’s ability to induce mutations, like base-pair substitutions or frameshifts, by counting revertants. It’s a rapid, cost-effective screen for environmental toxins, drugs, and pesticides, correlating ~85% with rodent carcinogenicity.

  Explanation of All Options

  Each option is evaluated based on the test’s design and scientific validation:

  • (A) The mutagenicity of a chemical
    Correct. The test quantifies mutations restoring histidine prototrophy in engineered strains with enhanced permeability (rfa mutation) and DNA repair defects (uvrB). Positive results signal DNA damage potential.

  • (B) Carcinogenicity of a chemical
    Incorrect as primary purpose. While mutagens often cause cancer, Ames tests mutagenicity directly, not tumor formation. It’s a preliminary screen; carcinogenicity requires animal studies like two-year rodent bioassays.

  • (C) Both mutagenicity and carcinogenicity of a chemical
    Incorrect. The assay lacks direct carcinogenesis measurement—no tumor endpoints or long-term exposure. It flags potential carcinogens via mutagenesis but isn’t dual-purpose.

  • (D) Toxicity of a chemical
    Incorrect. Toxicity involves broader effects like cell death or organ damage; Ames focuses on genetic mutations only. General toxicity uses assays like MTT or LD50, not reversion counts.

  Option	Measures	Key Mechanism	Ames Test Match?
  (A) Mutagenicity	DNA mutations	Revertant colonies	Yes
  (B) Carcinogenicity	Tumor formation	Animal models	No
  (C) Both	Mutations + tumors	Combined assays	No
  (D) Toxicity	Cell/organ damage	Viability assays	No

  Applications in Biotech and Limitations

  Used for drugs, cosmetics, and wastewater, the Ames test screens thousands of compounds yearly. Limitations include false positives/negatives and bacterial-human differences, so it’s paired with mammalian assays. For bioinformatics pros, integrate results with sequence analysis tools like BLAST for mutation hotspots.

  Master this for exams: Ames test determines mutagenicity exclusively.